Tag: Drug Procurement

Share of Public Procurement in Drug Sales in Russian Pharma Market Reached 34.4%

The share of public procurement in the overall structure of drug sales in Russian pharmaceutical market has reached 34.4% in the first half of 2019, which became a historical record figure for the cou...

FAS Russia uncovered a new cartel in public drug procurement

The Federal Antimonopoly Service of the Russian Federation opened the case based on the monitoring of public drug and medical products procurement. 'Axonmed' Ltd., 'Device' Ltd., 'InterMed' Ltd., '...

Nacimbio to provide extra 200 million units of blood products to Russian regions

Nacimbio concluded eight new contracts with the Ministry of Health of the Russian Federation for the supply of four units (INN) of blood plasma products.

Priority in drug procurement is considered the most effective to reduce imports

In 2018, the number of pharma companies supporting further restriction or ban on participation of foreign producers in public procurement, increased to 63%.

The Ministry of Health of Uzbekistan will reform drug provision

In 2018, 914.6 billion sums will be allocated to ensure the procurement of medicinal products and medical devices for state medical institutions in Uzbekistan, which is 2.5 times more than in 2017.

Kazakhstan’s Single Distributor will switch to e-procurement of medicines

The Minister of Health of Kazakhstan spoke about the issues related to provision of medicines to the people of Kazakhstan, including public procurement of medicinal products by the single distributor.

Kazakh pharma manufacturers will receive a 10-year guaranteed market

SK-Pharmacy LLC, the single distributor in Kazakhstan, announced a competitive bidding for long-term contracts with domestic manufacturers.

Kazakhstan added new TB drugs to its list of free medicines

A number of new innovative drugs were added to the list of free medicines including those for the treatment of tuberculosis. This was announced by the Kazakhstan’s Minister of Health Elzhan Birtanov at a public meeting.

Authorities are preparing additional preferences for Russian pharma manufacturers

A relevant draft order on additional preferences for manufacturers is being prepared for state registration in the Ministry of Justice, announced the press service of the Russian Ministry of Industry and Trade.

Pharmstandard will supply antiretroviral drug to Russian Ministry of Health

Pharmstandard turned out to be the only pharmaceutical company that made a bid for supplying rilpivirine + tenofovir + emtricitabine, a three-component antiretroviral medication included in the list of vital and essential drugs.

Russia will support pharmaceutical manufacturers with high level of localization

Russian Prime Minister Dmitry Medvedev signed the Decree No. 572 of May 12, 2018, aimed at supporting the manufacturers of medicinal products that perform all stages of production.

Kazakhstan will implement mechanisms to regulate drug prices

The mechanisms that will allow to regulate the prices of medicinal products in wholesale and retail trade will be introduced in accordance with the order of the President of Kazakhstan.

Nacimbio will supply blood products to Russian Ministry of Health

Nacimbio JSC, a pharmaceutical subsidiary of Rostec Corporation, signed four new contracts with the Russian Ministry of Health for 2018 supplies of blood-derived products under the Seven Nosologies program.

R-Pharm will supply Viekira Pak to Russian Ministry of Health

The Ministry of Health of the Russian Federation announced the results of the tender for supply of dasabuvir/ombitasvir/paritaprevir/ritonavir, a new drug for hepatitis C. As it was expected, the declared winner was R-Pharm.

49% of cancer drugs purchased by Russian Ministry were manufactured in Russia

According to IQVIA, in 2017, the Russian market of anti-tumor drugs was about 72 billion rubles in value terms and amounted to 14 million packages in physical terms.

GSK will supply medicines worth 1.1 billion rubles to Russian Ministry of Health

Since the start of 2018, GlaxoSmithKline Trading CJSC, the Russian division of British GSK, has won five competitive bids to supply the drugs against HIV, hepatitis B, C and tuberculosis.